Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases
Journal of Clinical Microbiology(2019)
Abstract
Here, we report comparable results for the Wako β-glucan test (GT; FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan), recently launched in Europe for testing the invasive fungal disease (IFD) biomarker 1,3-β-d-glucan (BDG) ([1][1][–][2][3][3]), in matched serum and plasma samples from
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined